PARIS, Oct 8 (Reuters) - Any plans to modify France's pension reforms - whose unpopularity is one of the reasons behind the country's political crisis - would be very costly for the economy, said ...

The International Atomic Energy Agency’s World Fusion Outlook 2025 report says there are more than 160 fusion devices now either operational, under construction or planned. (Image: IAEA/X) The ...

There are lots of hidden Brainrots to discover in Plants Vs Brainrots, and one of the ways to unlock them is to use the Fusion Machine. This won't be immediately available to you, however, as it's a ...

The two great technology revolutions of the modern era — artificial intelligence and renewable energy — are colliding. In September, more electricity was generated by solar and wind in Australia than ...

The U.S. Department of Transportation has announced significant changes to its Disadvantaged Business Enterprise program, which considers disadvantaged businesses when awarding billions for federal ...

Salesforce announced Monday the latest version of its AI agent platform as the company looks to lure enterprises to its AI software in an increasingly crowded market. The customer relations manager ...

Karwa Chauth 2025 calls for stunning mehndi. This guide offers unique, simple Indian designs, from moon motifs to couple silhouettes, perfect for celebrating love and tradition. Learn how to plan your ...

The Estimates data displayed by Moneycontrol is not a recommendation to buy or sell any securities. Estimates data is a third party aggregated data provided by S&P Global Market Intelligence LLC for ...

Meteorologists warn of sudden shifts from clear skies to cloud cover in coming days Meteorologists described the event as distinctive, noting that such hybrid systems are relatively rare during the ...

There is evidence that stress and glucocorticoids alter drug self-administration and mesolimbic dopamine (DA) activity in preclinical models. The primary purpose of this study was to test the ...

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...